Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. SLS
SLS logo

SLS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

SLS News

Sellas' Immunotherapy Trial Approaches Key Milestone

2d agostocktwits

Wall Street Rebounds Amid Oil Price Volatility

2d agostocktwits

Sellas Immunotherapy Advances with Galinpepimut-S

3d agostocktwits

Sellas Life Sciences Stock Volatility Amid AML Summit Insights

5d agostocktwits

Sellas Life Sciences Stock Soars Ahead of Key AML Trial Data

Mar 05 2026stocktwits

SELLAS Life Sciences Stock Surges Over 200% Amid Positive Trial Data

Mar 04 2026Benzinga

Sellas Life Sciences Stock Soars Ahead of Key AML Trial Data

Mar 04 2026stocktwits

SELLAS GPS Trial Progress Captivates Investors

Feb 27 2026stocktwits

SLS Events

03/06 08:50
Laser Photonics Corporation Borrow Rate Increases to 92.43%
Latest data shows the largest indicative borrow rate increases among liquid option names include: LASER PHOTONICS CORPORATION (LASE) 92.43% +33.52, Upexi (UPXI) 10.01% +2.18, Gold Bear 3x (DUST) 7.22% +1.92, Stubhub Holdings, Inc. (STUB) 25.14% +1.63, Kodiak AI, Inc. Common Stock (KDK) 43.33% +1.57, Medical Properties Trust, Inc (MPT) 2.08% +1.30, Direxion S&P Biotech Bull 3X (LABU) 15.63% +1.13, Lucid Group (LCID) 41.75% +1.04, Sellas Life Sciences (SLS) 16.90% +1.03, and SPDR S&P Insurance (KIE) 5.37% +1.01.
03/02 08:50
Liquid Option Borrow Rates Increase
Latest data shows the largest indicative borrow rate increases among liquid option names include: Opera Ltd (OPRA) 4.53% +3.34, PROSHARES ULTRA BITCOIN ETF (BITU) 4.30% +1.88, LASER PHOTONICS CORPORATION (LASE) 69.49% +1.53, Volatility Shares Trust XRP 2X ETF (XRPT) 7.19% +1.20, BTQ Technologies Corp. Common Stock (BTQ) 10.52% +0.81, Theravance Biopharma (TBPH) 5.90% +0.78, T-REX 2X INVERSE MSTR DAILY TARGET (MSTZ) 35.50% +0.56, Tidal Trust II (IRE) 39.69% +0.53, Fermi Inc. Common Stock (FRMI) 2.64% +0.49, and Sellas Life Sciences (SLS) 33.14% +0.42.
02/20 08:50
Liquid Option Borrow Rates Increase
Latest data shows the largest indicative borrow rate increases among liquid option names include: Sellas Life Sciences (SLS) 20.00% +1.62, MSOX ETF (MSOX) 14.83% +0.65, Humacyte (HUMA) 20.83% +0.62, Velo3D Inc (VELO) 11.75% +0.59, ProShares Ultra VIX Short Term Futures (UVXY) 6.69% +0.54, Americas Silver (USAS) 1.02% +0.52, Draganfly (DPRO) 13.60% +0.42, Palladyne AI Corp (PDYN) 23.10% +0.40, Teucrium 2x Long Daily XRP ETF (XXRP) 3.31% +0.31, and Sidus Space Inc (SIDU) 11.40% +0.31.

SLS Monitor News

Sellas Life Sciences Group Inc stock drops amid market strength

Jan 06 2026

SELLAS Life Sciences shares surge on positive REGAL trial updates

Jan 05 2026

Sellas Life Sciences Group Inc reaches 52-week high amid REGAL trial progress

Dec 29 2025

SLS Earnings Analysis

No Data

No Data

People Also Watch